{"gene":"CLK1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1997,"finding":"CLK1 kinase phosphorylates SR proteins and regulates alternative pre-mRNA splicing in vivo; the peptide domain encoded by the alternatively spliced exon of CLK1 is essential for this regulatory activity. CLK1 also autoregulates its own pre-mRNA splicing, producing catalytically active (CLK1) and truncated inactive (CLK1T) isoforms.","method":"In vivo expression/transfection assays, alternative splicing analysis of CLK1 and adenovirus pre-mRNAs","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo demonstration with domain-deletion mutants, replicated across multiple pre-mRNA targets including autoregulation","pmids":["9315658"],"is_preprint":false},{"year":1997,"finding":"C. elegans CLK-1 protein is structurally and functionally conserved with yeast Cat5p/Coq7p, a metabolic regulator; clk-1 complements cat5/coq7 null mutants, demonstrating shared biochemical function at the level of cellular physiology.","method":"Genetic complementation of yeast coq7/cat5 null mutants with C. elegans clk-1","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct genetic complementation across species, replicated in multiple subsequent studies","pmids":["9020081"],"is_preprint":false},{"year":1998,"finding":"Yeast Coq7p/Cat5p (CLK-1 homologue) is a mitochondrial inner membrane protein directly involved in ubiquinone biosynthesis; the defect in gluconeogenic gene activation in coq7/cat5 null mutants is a general consequence of defective respiration, not a direct regulatory role.","method":"Subcellular fractionation, mitochondrial localization assays, respiratory growth assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct fractionation and functional assays, consistent with multiple independent studies","pmids":["9452453"],"is_preprint":false},{"year":1999,"finding":"C. elegans CLK-1 fused to GFP is fully active and localizes to the mitochondria of all somatic cells. Overexpression of CLK-1 in wild-type worms increases mitochondrial activity, accelerates behavioral rates during aging, and shortens lifespan, demonstrating that clk-1 regulates and controls these processes.","method":"GFP fusion live imaging, in vivo dye-uptake assay for mitochondrial membrane potential, succinate cytochrome c reductase activity assay, overexpression studies","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization by GFP fusion, multiple functional assays, overexpression phenotype in vivo","pmids":["10202142"],"is_preprint":false},{"year":1999,"finding":"Human CLK-1 functionally complements yeast coq7 deletion mutants for growth on non-fermentable carbon sources, demonstrating conservation of the ubiquinone biosynthesis function from nematode to human.","method":"Yeast complementation assay with human CLK-1 cDNA introduced into coq7 deletion strains","journal":"Mammalian genome","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct complementation assay, single lab but definitive functional test","pmids":["10501970"],"is_preprint":false},{"year":1999,"finding":"CLK1 and CLK2 phosphorylate PTP-1B in vitro and in vivo, activating its phosphatase activity approximately 2-5-fold. Phosphorylation of PTP-1B at Ser50 by CLK1 is responsible for enzymatic activation.","method":"In vitro kinase assay, co-expression in HEK293 cells, site-directed mutagenesis (Ser50)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution plus mutagenesis plus cellular validation, single lab","pmids":["10480872"],"is_preprint":false},{"year":2000,"finding":"The N-terminus of CLK1 acts as a negative regulatory domain; N-terminal truncation causes a 45-fold increase in Vmax. CLK1 activity is positively regulated by phosphorylation on tyrosine residues or serine/threonine residues, and negatively regulated by phosphorylation of a subset of serine/threonine residues within the catalytic domain (PP2A treatment increases activity 2-6-fold; combined tyrosine + serine/threonine dephosphorylation abolishes activity). CLK1 protein is primarily found in the cytoplasm of neuronal cells, with only a small fraction in the nucleus.","method":"N-terminal truncation mutants, in vitro kinase assays, phosphatase (PP2A, tyrosine phosphatase) treatment, subcellular fractionation, immunofluorescence","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biochemical methods including truncation, phosphatase treatment, and localization, single lab","pmids":["10954422"],"is_preprint":false},{"year":2001,"finding":"CLK-1 is absolutely required for ubiquinone (UQ9) biosynthesis in C. elegans; clk-1 mutant mitochondria lack UQ9 and instead accumulate demethoxyubiquinone (DMQ9). DMQ9 can function as an electron carrier for both complex I and complex II, explaining near-normal respiration in mutants.","method":"Lipid analysis by HPLC/MS, synthesis of DMQ2, in vitro respiratory chain activity assays with isolated mitochondria","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical identification of substrate accumulation plus functional reconstitution, replicated independently","pmids":["11244089"],"is_preprint":false},{"year":2001,"finding":"Coq7/CLK-1 is a member of the di-iron carboxylate protein family based on a conserved sequence motif for iron ligands; the Pseudomonas aeruginosa Coq7 ortholog complements an E. coli ubiF mutant lacking 5-demethoxyubiquinone hydroxylase activity, providing evidence that Coq7 directly functions as a hydroxylase.","method":"Sequence analysis, identification of di-iron motif, bacterial complementation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bacterial complementation confirms hydroxylase function, di-iron motif identification by sequence; single lab","pmids":["11435415"],"is_preprint":false},{"year":2001,"finding":"Mouse CLK-1 (mCLK1) is imported into the mitochondrial matrix where a leader sequence is cleaved and the protein becomes loosely associated with the inner membrane. Unusually, this import does not require a mitochondrial membrane potential, unlike all other known mitochondrial proteins with cleavable pre-sequences.","method":"Subcellular fractionation, mitochondrial import assays with membrane potential disruption, pulse-chase/processing assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct fractionation and functional import assays with membrane potential manipulation, mechanistically definitive","pmids":["11387338"],"is_preprint":false},{"year":2001,"finding":"Human PRP4 (hPRP4) interacts directly with CLK1 at its C-terminus; the RS-rich domain of hPRP4 is phosphorylated by CLK1 in vitro. Overexpression of active CLK1 causes redistribution of hPRP4 from nuclear speckles to a diffuse nucleoplasmic pattern, while catalytically inactive CLK1 does not.","method":"Co-immunoprecipitation, in vitro kinase assay, indirect immunofluorescence, overexpression of wild-type and kinase-dead CLK1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction, in vitro phosphorylation, and functional localization change all demonstrated, single lab","pmids":["11418604"],"is_preprint":false},{"year":2002,"finding":"C. elegans CLK-1 and mouse CLK-1 have DNA-binding activity specific to the OL region of mitochondrial DNA; this DNA-binding activity is inhibited by ADP and is altered by clk-1 mutations that extend lifespan, suggesting a possible role in mtDNA replication or transcription regulation.","method":"In vitro DNA-binding assay (electrophoretic mobility shift), ADP inhibition experiment","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single in vitro binding assay, single lab, no functional validation of the DNA-binding activity in vivo","pmids":["11959146"],"is_preprint":false},{"year":2003,"finding":"CLK-1 is a hydroxylase catalyzing the conversion of demethoxyubiquinone to hydroxyubiquinone (a ubiquinone precursor); C. elegans CLK-1 expressed from a plasmid rescues aerobic respiration on a non-fermentable carbon source and restores ubiquinone biosynthesis in an E. coli ubiF mutant, providing direct evidence of demethoxyubiquinone hydroxylase activity.","method":"Bacterial complementation of E. coli ubiF mutant, respiratory growth assay, ubiquinone biosynthesis assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic complementation demonstrating hydroxylase activity, consistent with multiple independent lines of evidence","pmids":["12753928"],"is_preprint":false},{"year":2010,"finding":"Mouse CLK-1 (MCLK1) belongs to the carboxylate-bridged diiron protein family, confirmed by Mössbauer and EPR spectroscopy. NADH can serve directly as a reductant for catalytic activation of dioxygen and substrate oxidation by MCLK1 in vitro, with no requirement for an additional reductase protein component.","method":"Mössbauer spectroscopy, EPR spectroscopy, in vitro enzymatic activity assay with NADH and quinone substrates","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — spectroscopic structural characterization plus in vitro enzymatic activity with defined reductant, single lab but rigorous biophysical methods","pmids":["20923139"],"is_preprint":false},{"year":2011,"finding":"Splicing of CLK1/4 mRNAs is normally suspended with intron-retaining intermediate forms pooled in the nucleus. Under stress conditions (heat shock, osmotic stress), maturation of CLK1/4 mRNAs is promoted, leading to translation of CLK1/4 proteins that catalyze rephosphorylation of SR proteins (especially SRSF4 and SRSF10), thereby restoring the phosphorylation state of SR proteins after stress-induced dephosphorylation.","method":"RT-PCR for intron-retaining forms, CLK-specific inhibitor TG003, stress induction, SR protein phosphorylation assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition plus stress induction with defined molecular readouts, single lab but multiple orthogonal approaches","pmids":["21949414"],"is_preprint":false},{"year":2013,"finding":"CLK1 phosphorylates SPF45 (alternative splicing factor 45) on eight serine residues. CLK1 phosphorylation of SPF45 regulates its splice-site utilization (Fas mRNA exon 6 exclusion), enhances SPF45 protein stability (CLK1 inhibition increases SPF45 proteasomal degradation), and promotes ovarian cancer cell migration and invasion.","method":"In vitro kinase assay, mutagenesis of phosphorylation sites, CLK1 inhibition/overexpression, proteasome inhibitor experiments, RT-PCR for Fas splicing, migration/invasion assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay with mutagenesis plus cellular functional validation across multiple readouts, single lab","pmids":["23519612"],"is_preprint":false},{"year":2014,"finding":"The N-terminus of CLK1 contacts both the CLK1 kinase domain and the RS domain of SR protein SRSF1, facilitating hyperphosphorylation and cooperative RNA binding by SRSF1. The N-terminus enhances total phosphoryl content of SRSF1, SRSF2, SRSF5 and Tra2β1 by 2-3-fold, acting as a bridge connecting the kinase domain to the RS domain substrate.","method":"In vitro kinase assays with truncation mutants, RNA binding assays (EMSA), phosphorylation stoichiometry measurements","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro with N-terminal domain mutants and multiple substrates, single lab with multiple orthogonal methods","pmids":["24869919"],"is_preprint":false},{"year":2015,"finding":"C. elegans CLK-1 has a distinct nuclear form that independently regulates lifespan through a retrograde signaling pathway conserved from C. elegans to humans. Nuclear CLK-1 responds to mitochondrial reactive oxygen species, modulates gene expression to regulate mitochondrial ROS metabolism and the mitochondrial unfolded protein response.","method":"Subcellular fractionation, nuclear/mitochondrial CLK-1 separation, ROS measurement, lifespan assays with nuclear-specific CLK-1 constructs, gene expression analysis","journal":"Nature cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation plus functional lifespan and gene expression data, but contradicted by a subsequent paper (PMID 28404998) that failed to detect nuclear enrichment","pmids":["25961505"],"is_preprint":false},{"year":2015,"finding":"CLK1 uses N-terminus-induced oligomerization (rather than a classical docking groove or adaptor) as a substrate selection mechanism for SR proteins. The disordered N-terminus induces oligomerization necessary for preferential phosphorylation of SRSF1 over non-physiological substrates; CLK1 self-association occurs in the nucleus and drives localization to nuclear speckles.","method":"In vitro kinase specificity assays at varying concentrations, size-exclusion chromatography, N-terminal truncation mutants, nuclear localization by immunofluorescence","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical approaches supporting oligomerization mechanism, single lab","pmids":["26443864"],"is_preprint":false},{"year":2016,"finding":"SRPK1 interacts with an RS-like domain in the N-terminus of CLK1 to facilitate release of phosphorylated SR proteins from CLK1, enabling efficient splice-site recognition and spliceosome assembly. CLK1 alone cannot release phosphorylated SR proteins (thus inactivating them); SRPK1 provides the release function in a symbiotic kinase system.","method":"Co-immunoprecipitation, in vitro splicing assays, CLK1/SRPK1 interaction mapping, SR protein release assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, functional in vitro splicing assay, domain mapping; single lab with multiple orthogonal methods and mechanistically rigorous","pmids":["27397683"],"is_preprint":false},{"year":2017,"finding":"All phenotypes of C. elegans clk-1 mutants (behavioral, developmental, lifespan, mitochondrial quality control gene expression) result exclusively from loss of ubiquinone biosynthesis; pharmacological restoration of UQ biosynthesis rescues all phenotypes. Nuclear localization of MCLK1/CLK-1 could not be detected by immunohistochemistry or protein purification.","method":"Pharmacological UQ restoration in clk-1 null mutants, immunohistochemical localization in worms, subcellular fractionation of mammalian cells, lifespan and behavioral assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological rescue plus negative localization result with multiple methods, directly addresses disputed nuclear function claim","pmids":["28404998"],"is_preprint":false},{"year":2017,"finding":"CLK1 inhibition (TG693, an orally available inhibitor) promotes skipping of the mutated exon 31 in DMD patient-derived cells and increases production of functional exon-31-skipped dystrophin. Oral administration to mice inhibits phosphorylation of SR protein substrates of CLK1 and modulates pre-mRNA splicing in skeletal muscle in vivo.","method":"Patient-derived cell splicing assays, Western blotting for dystrophin, oral dosing in mice, SR protein phosphorylation assays in skeletal muscle","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cellular and in vivo functional validation of CLK1 substrate phosphorylation and splicing modulation, single lab","pmids":["28555643"],"is_preprint":false},{"year":2019,"finding":"CLK1 regulates splicing of influenza A virus mRNA segment 7 (encoding M1/M2 proteins); CLK1 knockdown reduces influenza replication and increases splicing of segment 7. CLK1-/- mice support lower levels of influenza virus replication than wild-type mice.","method":"siRNA knockdown in A549 cells, CLK1 knockout mice challenged with influenza, RT-PCR for M1/M2 splicing, viral titer assays","journal":"Antiviral research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — both cell-based knockdown and in vivo knockout with defined molecular readout (viral mRNA splicing), single lab","pmids":["31176694"],"is_preprint":false},{"year":2020,"finding":"Trypanosoma brucei CLK1 (KKT10) is a kinetochore kinase; amidobenzimidazole (AB1) inhibitors irreversibly inhibit TbCLK1 via a Michael acceptor bond with Cys215 in the ATP-binding pocket. Chemical inhibition of CLK1 impairs inner kinetochore recruitment and compromises cell-cycle progression leading to cell death.","method":"Co-crystal structure of TbCLK1 with AB1 inhibitor, biochemical target deconvolution with 29 kinase overexpression mutants, cell biology/cell-cycle assays","journal":"Nature microbiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus biochemical inhibition mechanism plus genetic target validation and cell-cycle phenotype","pmids":["32661312"],"is_preprint":false},{"year":2021,"finding":"CLK1 phosphorylates Ser-226 in the C-terminus of U1-70K, releasing it from subnuclear granules and facilitating interaction with U1 snRNP and SR protein SRSF1. CLK1 breaks contacts between the C-terminus and the RNA recognition motif (RRM) of U1-70K, permitting stable interactions with U1 snRNP-associated proteins. Nuclear induction of SRPK1 facilitates CLK1 dissociation from U1-70K to recycle the kinase.","method":"Quantitative phosphoproteomics, in vitro kinase assays, co-immunoprecipitation, subnuclear localization by immunofluorescence, SRPK1 nuclear induction experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphoproteomics identification plus in vitro validation plus functional protein-protein interaction assays, single lab with multiple orthogonal methods","pmids":["33811140"],"is_preprint":false},{"year":2021,"finding":"CLK1 phosphorylates SRSF5 at Ser250, which inhibits METTL14 exon 10 skipping while promoting Cyclin L2 exon 6.3 skipping in pancreatic cancer cells. The CLK1/SRSF5 axis thereby promotes pancreatic cancer cell growth and metastasis through these two alternative splicing events.","method":"Phosphorylation mass spectrometry identifying SRSF5-Ser250, RNA-seq for splicing events, RIP assays, RNA pulldown, CLIP-qPCR, in vitro and in vivo tumor models","journal":"Journal of hematology & oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphorylation site identified by MS with functional splicing validation by multiple RNA methods, single lab","pmids":["33849617"],"is_preprint":false},{"year":2021,"finding":"Trypanosoma brucei KKT2 is a direct substrate of CLK1; phosphorylation of KKT2 at Ser508 by CLK1 is essential for KKT2 function and for kinetochore assembly. Chemical inhibition of CLK1 with AB1 impairs inner kinetochore recruitment. CLK1 and aurora kinase AUK1 are in separate regulatory pathways for KKT2 phosphorylation.","method":"In vitro kinase assay, site-directed mutagenesis of KKT2-S508, chemical inhibition with AB1, immunofluorescence for kinetochore assembly, AUK1 inhibitor epistasis experiment","journal":"mBio","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation plus mutagenesis plus functional kinetochore assembly assay, single lab but multiple orthogonal methods","pmids":["34128702"],"is_preprint":false},{"year":2021,"finding":"CLK1 inhibition of CLK1 downregulates the functional ERCC1-202 isoform through altered alternative splicing, resulting in enhanced DNA damage and apoptosis. CLK1 knockdown is synthetically lethal with PARP inhibitors in ovarian cancer, and the combination of olaparib with CLK1 inhibitor TG003 shows potent anti-proliferative effects in vitro and in vivo.","method":"Genome-wide CRISPR-Cas9 screen, siRNA knockdown, CLK1 inhibitor TG003, ERCC1 isoform RT-PCR, DNA damage markers, in vivo xenograft experiments","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR screen plus mechanistic validation of ERCC1 isoform switching, single lab","pmids":["41191919"],"is_preprint":false},{"year":2021,"finding":"CLK1 phosphorylates THRAP3 at Ser243; phosphorylated THRAP3 interacts with phosphorylated PPARγ to impair adipose tissue browning and insulin sensitivity. CLK1 genetic knockout or chemical inhibition in mice ameliorates diet-induced obesity and insulin resistance.","method":"Phosphoproteomics, co-immunoprecipitation, site-directed mutagenesis (Ser243), CLK1 knockout mice, metabolic phenotyping","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics plus co-IP plus in vivo genetic validation, single lab","pmids":["34526909"],"is_preprint":false},{"year":2024,"finding":"CLK1 exon 4 inclusion is controlled by a balance between TRA2 protein activators and CLK1-phosphorylated SRSF3 as a repressor; SRSF10 and SRSF12 interact with TRA2 proteins to prevent their enhancer activity, allowing SRSF3 to enforce exon 4 skipping. An exonic enhancer in exon 4 interacts with TRA2β. CLK1 kinase inhibitors antagonize the repressor activity of SRSF10, SRSF12, and SRSF3 in this autoregulatory loop.","method":"CRISPR/Cas9 knockouts, tagged protein expression, CRISPR/dCas13Rx, RNA immunoprecipitation, CLK1 inhibitor treatment","journal":"RNA","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic tools and RNA-protein interaction assays, single lab","pmids":["39251328"],"is_preprint":false},{"year":2025,"finding":"CLK1 activates YAP to promote intrahepatic cholangiocarcinoma (ICC); WWC2 was identified as a potential mediator of the CLK1-YAP cascade by 4D label-free mass spectrometry and co-immunoprecipitation. Loss of YAP completely retards AKT/CLK1-induced ICC tumor formation in mice.","method":"RNA sequencing, 4D label-free mass spectrometry, co-immunoprecipitation, hydrodynamic transfection mouse model, YAP inhibition/deletion experiments","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS identification of binding partner plus co-IP plus in vivo genetic rescue, single lab","pmids":["39693605"],"is_preprint":false},{"year":2025,"finding":"cALG8 (a circRNA) functions as a protein scaffold enabling CLK1 to phosphorylate SRSF7 at Ser231, facilitating SRSF7-dependent alternative splicing of ATM kinase to produce the ATM203 variant, which enhances ATM translation, DNA damage repair, and immune microenvironment remodeling to promote gemcitabine resistance in pancreatic cancer.","method":"LC-MS for RNA-binding proteins, molecular biology validation of cALG8-CLK1-SRSF7 interaction, phospho-specific detection, splice variant analysis, PDO/PDX models","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry identification plus mechanistic validation in patient-derived models, single lab","pmids":["40840404"],"is_preprint":false}],"current_model":"CLK1 (COQ7/CLK-1) is a dual-specificity kinase with two well-established mechanistic roles: (1) as a mitochondrial diiron hydroxylase that catalyzes the conversion of demethoxyubiquinone to hydroxyubiquinone in the ubiquinone biosynthesis pathway (a function conserved from bacteria to humans), imported into the mitochondrial matrix via an unusual membrane-potential-independent mechanism; and (2) as a nuclear serine-arginine protein kinase that hyperphosphorylates SR splicing factors (including SRSF1, SRSF2, SRSF4, SRSF5, SRSF10) and other spliceosomal components (U1-70K, SPF45), with substrate selectivity conferred by N-terminus-driven oligomerization, and whose activity is regulated through a symbiotic relationship with SRPK1 that enables release of phosphorylated SR proteins to promote spliceosome assembly; CLK1 also autoregulates its own alternative splicing and controls diverse downstream splicing events linked to cancer, viral replication, and neurodegenerative disease."},"narrative":{"mechanistic_narrative":"The CLK1 symbol in this corpus resolves to two biochemically distinct proteins that share the historical \"clk-1\" designation: a nuclear/cytoplasmic dual-specificity SR-protein kinase, and the mitochondrial ubiquinone-biosynthesis enzyme encoded by the COQ7/CLK-1 ortholog. The kinase activity governs alternative pre-mRNA splicing by hyperphosphorylating SR splicing factors, and CLK1 autoregulates its own splicing to produce a catalytically active isoform and a truncated inactive isoform (CLK1T) through an exon-inclusion loop balanced between TRA2 activators and CLK1-phosphorylated SRSF3 repressor activity [PMID:9315658, PMID:39251328]. Substrate selectivity is conferred by the disordered N-terminus, which acts both as a negative regulatory domain and as a bridge that contacts the kinase domain and the RS domain of substrates such as SRSF1, driving N-terminus-induced oligomerization and localization to nuclear speckles [PMID:10954422, PMID:24869919, PMID:26443864]. CLK1 phosphorylates a broad set of spliceosomal substrates — including SRSF5, U1-70K (Ser226), SPF45, and the splicing kinase target hPRP4 — to control splice-site usage and spliceosome assembly, and operates in a symbiotic system with SRPK1, which binds an RS-like motif in the CLK1 N-terminus to release phosphorylated SR proteins and recycle the kinase [PMID:11418604, PMID:23519612, PMID:27397683, PMID:33811140, PMID:33849617]. Under cellular stress, suspended intron-retaining CLK1/4 transcripts mature to restore SR-protein phosphorylation [PMID:21949414]. Through these splicing functions CLK1 modulates influenza M1/M2 segment-7 splicing and viral replication, DMD exon skipping, and multiple cancer-associated splicing programs (ERCC1, METTL14/Cyclin L2, ATM), the latter conferring PARP-inhibitor synthetic lethality and chemoresistance phenotypes [PMID:28555643, PMID:31176694, PMID:33849617, PMID:41191919, PMID:40840404]. The independently characterized mitochondrial COQ7/CLK-1 protein is a carboxylate-bridged diiron hydroxylase that converts demethoxyubiquinone to hydroxyubiquinone in ubiquinone biosynthesis, a function conserved from bacteria and yeast to nematode and human, imported into the matrix by an unusual membrane-potential-independent mechanism; loss of this activity, not any nuclear role, accounts for the C. elegans clk-1 lifespan and mitochondrial phenotypes [PMID:9020081, PMID:10501970, PMID:11244089, PMID:11387338, PMID:12753928, PMID:20923139, PMID:28404998]. In the divergent trypanosome ortholog (KKT10), CLK1 instead functions as a kinetochore kinase that phosphorylates KKT2 to drive kinetochore assembly and cell-cycle progression [PMID:32661312, PMID:34128702].","teleology":[{"year":1997,"claim":"Established that CLK1 is a functional regulator of alternative splicing and uncovered its self-governing isoform switch, defining the kinase as both an effector and target of splicing control.","evidence":"In vivo transfection and alternative splicing analysis with domain-deletion mutants on CLK1 and adenovirus pre-mRNAs","pmids":["9315658"],"confidence":"High","gaps":["Did not identify the full SR substrate spectrum","Mechanism of substrate selection not yet defined"]},{"year":1999,"claim":"Resolved that the clk-1 gene shared with the splicing kinase symbol actually encodes a conserved mitochondrial metabolic enzyme, separating the metabolic ortholog from the kinase function.","evidence":"Cross-species genetic complementation of yeast coq7/cat5 nulls with C. elegans and human clk-1, plus GFP localization in worms","pmids":["9020081","9452453","10501970","10202142"],"confidence":"High","gaps":["Did not yet define the enzymatic reaction catalyzed","Did not address whether the kinase and metabolic activities reside in the same human protein"]},{"year":1999,"claim":"Showed CLK1 kinase has substrates beyond SR proteins, demonstrating phosphorylation-dependent activation of PTP-1B at Ser50.","evidence":"In vitro kinase assay, HEK293 co-expression, and Ser50 site-directed mutagenesis","pmids":["10480872"],"confidence":"High","gaps":["Physiological context of PTP-1B activation not established","Not linked to splicing pathway"]},{"year":2000,"claim":"Defined the N-terminus as an autoinhibitory domain and revealed multi-site phosphorylation as a bidirectional regulator of kinase output, framing CLK1 activity as tightly tuned.","evidence":"N-terminal truncation mutants, in vitro kinase assays, PP2A/tyrosine phosphatase treatment, and subcellular fractionation","pmids":["10954422"],"confidence":"High","gaps":["Identities of the regulatory phospho-sites not mapped","Upstream kinases/phosphatases not identified"]},{"year":2001,"claim":"Pinned the metabolic ortholog's role to ubiquinone biosynthesis and clarified why respiration persists in mutants, by identifying DMQ9 accumulation as a partially functional electron carrier.","evidence":"HPLC/MS lipid analysis and in vitro respiratory chain assays in C. elegans mitochondria, plus mitochondrial import assays with membrane-potential disruption","pmids":["11244089","11387338"],"confidence":"High","gaps":["Mechanism of potential-independent import not structurally defined","Catalytic chemistry not yet characterized"]},{"year":2001,"claim":"Identified hPRP4 as a direct CLK1 interactor and substrate, extending kinase targets to core spliceosomal regulators and linking CLK1 activity to speckle dynamics.","evidence":"Co-immunoprecipitation, in vitro kinase assay, and immunofluorescence with wild-type vs kinase-dead CLK1","pmids":["11418604"],"confidence":"High","gaps":["Functional splicing consequence of hPRP4 phosphorylation not quantified"]},{"year":2003,"claim":"Defined the metabolic ortholog as a diiron-carboxylate demethoxyubiquinone hydroxylase, assigning its precise enzymatic reaction.","evidence":"E. coli ubiF complementation, di-iron motif analysis, and Mössbauer/EPR spectroscopy with NADH-driven in vitro turnover","pmids":["11435415","12753928","20923139"],"confidence":"High","gaps":["Human enzyme structure not solved","Physiological reductant in mammalian mitochondria not confirmed"]},{"year":2011,"claim":"Connected CLK1 isoform maturation to stress signaling, showing intron-retained transcripts are released to rephosphorylate SR proteins and restore splicing homeostasis.","evidence":"RT-PCR of intron-retaining forms, stress induction, and CLK inhibitor TG003 with SR phosphorylation readouts","pmids":["21949414"],"confidence":"High","gaps":["Signal coupling stress to intron removal not defined","SR substrate breadth under stress not fully mapped"]},{"year":2014,"claim":"Explained how CLK1 achieves SR-protein hyperphosphorylation, showing the N-terminus bridges the kinase and RS domains to enhance phosphoryl content and cooperative RNA binding.","evidence":"In vitro kinase assays with truncation mutants, EMSA, and phosphorylation stoichiometry on SRSF1/2/5 and Tra2β1","pmids":["24869919"],"confidence":"High","gaps":["Structural basis of the N-terminal bridge not solved"]},{"year":2015,"claim":"Proposed N-terminus-induced oligomerization as the substrate-discrimination mechanism, distinguishing physiological from non-physiological targets without a docking groove.","evidence":"Concentration-dependent in vitro specificity assays, size-exclusion chromatography, and speckle localization","pmids":["26443864"],"confidence":"Medium","gaps":["Oligomer stoichiometry in cells not defined","Single-lab biochemical model"]},{"year":2015,"claim":"Advanced a contested model that a nuclear CLK-1 form drives lifespan via mitochondrial ROS retrograde signaling, independent of the metabolic enzyme role.","evidence":"Subcellular fractionation, nuclear-specific constructs, ROS measurement, and lifespan assays in C. elegans","pmids":["25961505"],"confidence":"Medium","gaps":["Nuclear localization later not reproduced (#20)","Mechanism of retrograde gene-expression control undefined"]},{"year":2016,"claim":"Resolved how phosphorylated SR proteins are released from the kinase, establishing a symbiotic CLK1–SRPK1 system required for spliceosome assembly.","evidence":"Reciprocal co-IP, domain mapping of the CLK1 N-terminal RS-like motif, and in vitro splicing/SR-release assays","pmids":["27397683"],"confidence":"High","gaps":["In vivo stoichiometry of CLK1:SRPK1 not measured","Regulation of the handoff not defined"]},{"year":2017,"claim":"Definitively attributed all C. elegans clk-1 phenotypes to lost ubiquinone biosynthesis and failed to detect nuclear CLK-1, directly disputing the retrograde nuclear-signaling model.","evidence":"Pharmacological UQ restoration, immunohistochemistry, and fractionation in worms and mammalian cells","pmids":["28404998"],"confidence":"High","gaps":["Does not exclude condition-specific nuclear pools","Addresses the metabolic ortholog, not the human splicing kinase"]},{"year":2017,"claim":"Demonstrated translatable splicing control by CLK1, showing inhibition promotes therapeutic DMD exon skipping in patient cells and modulates SR phosphorylation in vivo.","evidence":"Patient-derived cell splicing assays, dystrophin Western blots, and oral TG693 dosing in mice","pmids":["28555643"],"confidence":"Medium","gaps":["Direct SR substrate driving exon 31 skipping not specified","Single-lab in vivo evidence"]},{"year":2021,"claim":"Mapped specific CLK1 phospho-sites and their splicing/assembly consequences across multiple substrates, building a residue-level picture of how CLK1 controls spliceosome dynamics and cancer-relevant splicing.","evidence":"Phosphoproteomics, in vitro kinase assays, mutagenesis, co-IP, and RNA-based splicing readouts on SPF45, U1-70K(Ser226), and SRSF5(Ser250)","pmids":["23519612","33811140","33849617"],"confidence":"High","gaps":["Comprehensive substrate-site map still incomplete","Cross-talk between sites not resolved"]},{"year":2020,"claim":"Revealed a divergent role of the trypanosome CLK1 ortholog (KKT10) as a kinetochore kinase phosphorylating KKT2 to drive kinetochore assembly and cell-cycle progression.","evidence":"Co-crystal structure with AB1 inhibitor, target deconvolution with kinase mutants, in vitro kinase assay/mutagenesis of KKT2-Ser508, and cell-cycle assays","pmids":["32661312","34128702"],"confidence":"High","gaps":["Relationship to the mammalian splicing-kinase function not established","Whether human CLK1 has any kinetochore role unknown"]},{"year":2021,"claim":"Linked CLK1 splicing control to therapeutic vulnerabilities and metabolic disease, including PARP-inhibitor synthetic lethality via ERCC1 isoform switching and THRAP3-PPARγ-mediated insulin resistance.","evidence":"Genome-wide CRISPR screen, ERCC1 isoform RT-PCR, xenografts, and phosphoproteomics/co-IP plus CLK1 knockout metabolic phenotyping in mice","pmids":["41191919","34526909"],"confidence":"Medium","gaps":["Direct substrate driving ERCC1-202 switching not pinpointed","Single-lab in vivo metabolic models"]},{"year":2024,"claim":"Dissected the molecular logic of CLK1 autoregulation, defining a TRA2-activator versus CLK1-phosphorylated SRSF3-repressor balance at exon 4.","evidence":"CRISPR/Cas9 knockouts, dCas13Rx, RNA immunoprecipitation, and CLK1 inhibitor treatment","pmids":["39251328"],"confidence":"Medium","gaps":["Quantitative contribution of each factor not resolved","Single-lab system"]},{"year":2025,"claim":"Extended CLK1's oncogenic splicing reach to chemoresistance and signaling, showing circRNA-scaffolded SRSF7 phosphorylation drives ATM splicing and a CLK1-YAP cascade in liver/pancreatic cancers.","evidence":"LC-MS for RNA-binding proteins, co-IP, phospho-specific and splice-variant analysis, and PDO/PDX and hydrodynamic mouse models","pmids":["40840404","39693605"],"confidence":"Medium","gaps":["Direct CLK1-YAP mechanism (WWC2 role) not fully validated","Single-lab models"]},{"year":null,"claim":"Whether the human CLK1 splicing kinase and the mitochondrial COQ7/CLK-1 hydroxylase are truly the same gene product or distinct proteins conflated by symbol history, and how their respective regulatory inputs integrate, remains unresolved in this corpus.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single study demonstrates both activities in one human protein","Structural model of human kinase N-terminal regulation lacking","In vivo SRPK1 handoff dynamics not quantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,5,10,15,16,24,25,26]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[7,8,12,13]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,14,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,19]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,3,7,9]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,14,18,24]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[10,18]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,14,19,24,29]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,12]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[23,26]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[22,25,27,30,31]}],"complexes":[],"partners":["SRPK1","SRSF1","U1-70K","SPF45","PRP4","SRSF5","KKT2","PTP-1B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49759","full_name":"Dual specificity protein kinase CLK1","aliases":["CDC-like kinase 1"],"length_aa":484,"mass_kda":57.3,"function":"Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1 (PubMed:10480872, PubMed:19168442). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells (PubMed:19168442)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49759/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLK1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLK1","total_profiled":1310},"omim":[{"mim_id":"618532","title":"CLK4-ASSOCIATING SERINE/ARGININE-RICH PROTEIN; CLASRP","url":"https://www.omim.org/entry/618532"},{"mim_id":"612502","title":"COLLECTIN 11; COLEC11","url":"https://www.omim.org/entry/612502"},{"mim_id":"612172","title":"DEAD-BOX HELICASE 23; DDX23","url":"https://www.omim.org/entry/612172"},{"mim_id":"609434","title":"LUC7-LIKE 3 PRE-mRNA SPLICING FACTOR; LUC7L3","url":"https://www.omim.org/entry/609434"},{"mim_id":"606093","title":"PEPTIDYL-PROLYL ISOMERASE G; PPIG","url":"https://www.omim.org/entry/606093"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear membrane","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CLK1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P49759","domains":[{"cath_id":"3.30.200.20","chopping":"156-243","consensus_level":"high","plddt":95.9514,"start":156,"end":243},{"cath_id":"1.10.510.10","chopping":"247-481","consensus_level":"high","plddt":96.4141,"start":247,"end":481}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49759","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49759-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49759-F1-predicted_aligned_error_v6.png","plddt_mean":79.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLK1","jax_strain_url":"https://www.jax.org/strain/search?query=CLK1"},"sequence":{"accession":"P49759","fasta_url":"https://rest.uniprot.org/uniprotkb/P49759.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49759/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49759"}},"corpus_meta":[{"pmid":"7768437","id":"PMC_7768437","title":"Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral timing.","date":"1995","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7768437","citation_count":348,"is_preprint":false},{"pmid":"9020081","id":"PMC_9020081","title":"Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9020081","citation_count":255,"is_preprint":false},{"pmid":"10202142","id":"PMC_10202142","title":"CLK-1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10202142","citation_count":235,"is_preprint":false},{"pmid":"10335847","id":"PMC_10335847","title":"A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-C and clk-1 mutants.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10335847","citation_count":191,"is_preprint":false},{"pmid":"20956340","id":"PMC_20956340","title":"Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20956340","citation_count":170,"is_preprint":false},{"pmid":"11244089","id":"PMC_11244089","title":"Altered quinone biosynthesis in the long-lived clk-1 mutants of Caenorhabditis elegans.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11244089","citation_count":168,"is_preprint":false},{"pmid":"11136229","id":"PMC_11136229","title":"A dietary source of coenzyme Q is essential for growth of long-lived Caenorhabditis elegans clk-1 mutants.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11136229","citation_count":155,"is_preprint":false},{"pmid":"9315658","id":"PMC_9315658","title":"In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9315658","citation_count":153,"is_preprint":false},{"pmid":"21949414","id":"PMC_21949414","title":"Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21949414","citation_count":132,"is_preprint":false},{"pmid":"17179669","id":"PMC_17179669","title":"Identification and characterization of a novel human collectin CL-K1.","date":"2006","source":"Microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17179669","citation_count":122,"is_preprint":false},{"pmid":"9452453","id":"PMC_9452453","title":"Yeast Clk-1 homologue (Coq7/Cat5) is a mitochondrial protein in coenzyme Q synthesis.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9452453","citation_count":110,"is_preprint":false},{"pmid":"11435415","id":"PMC_11435415","title":"A new member of the family of di-iron carboxylate proteins. Coq7 (clk-1), a membrane-bound hydroxylase involved in ubiquinone biosynthesis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11435415","citation_count":108,"is_preprint":false},{"pmid":"33849617","id":"PMC_33849617","title":"CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","date":"2021","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33849617","citation_count":102,"is_preprint":false},{"pmid":"27397683","id":"PMC_27397683","title":"Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27397683","citation_count":81,"is_preprint":false},{"pmid":"22475410","id":"PMC_22475410","title":"Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1).","date":"2012","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22475410","citation_count":79,"is_preprint":false},{"pmid":"24568585","id":"PMC_24568585","title":"Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.","date":"2014","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/24568585","citation_count":76,"is_preprint":false},{"pmid":"25961505","id":"PMC_25961505","title":"A nuclear role for the respiratory enzyme CLK-1 in regulating mitochondrial stress responses and longevity.","date":"2015","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25961505","citation_count":76,"is_preprint":false},{"pmid":"27377710","id":"PMC_27377710","title":"The collectins CL-L1, CL-K1 and CL-P1, and their roles in complement and innate immunity.","date":"2016","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27377710","citation_count":71,"is_preprint":false},{"pmid":"10649290","id":"PMC_10649290","title":"clk-1, mitochondria, and physiological rates.","date":"2000","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10649290","citation_count":66,"is_preprint":false},{"pmid":"10480872","id":"PMC_10480872","title":"The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10480872","citation_count":64,"is_preprint":false},{"pmid":"9450334","id":"PMC_9450334","title":"clk1, a serine/threonine protein kinase-encoding gene, is involved in pathogenicity of Colletotrichum lindemuthianum on common bean.","date":"1998","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/9450334","citation_count":63,"is_preprint":false},{"pmid":"23519612","id":"PMC_23519612","title":"Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23519612","citation_count":60,"is_preprint":false},{"pmid":"29025968","id":"PMC_29025968","title":"Activation of AMPK/mTORC1-Mediated Autophagy by Metformin Reverses Clk1 Deficiency-Sensitized Dopaminergic Neuronal Death.","date":"2017","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29025968","citation_count":60,"is_preprint":false},{"pmid":"11418604","id":"PMC_11418604","title":"Cloning of human PRP4 reveals interaction with Clk1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11418604","citation_count":57,"is_preprint":false},{"pmid":"10501970","id":"PMC_10501970","title":"Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10501970","citation_count":56,"is_preprint":false},{"pmid":"23954398","id":"PMC_23954398","title":"Characterization of the interaction between collectin 11 (CL-11, CL-K1) and nucleic acids.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23954398","citation_count":53,"is_preprint":false},{"pmid":"32661312","id":"PMC_32661312","title":"Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors.","date":"2020","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32661312","citation_count":52,"is_preprint":false},{"pmid":"27769915","id":"PMC_27769915","title":"Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming.","date":"2016","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27769915","citation_count":50,"is_preprint":false},{"pmid":"22301270","id":"PMC_22301270","title":"An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1).","date":"2011","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/22301270","citation_count":50,"is_preprint":false},{"pmid":"32333232","id":"PMC_32333232","title":"Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.","date":"2020","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/32333232","citation_count":49,"is_preprint":false},{"pmid":"28555643","id":"PMC_28555643","title":"Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28555643","citation_count":49,"is_preprint":false},{"pmid":"10954422","id":"PMC_10954422","title":"Biochemical characterization and localization of the dual specificity kinase CLK1.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10954422","citation_count":48,"is_preprint":false},{"pmid":"18927074","id":"PMC_18927074","title":"The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18927074","citation_count":48,"is_preprint":false},{"pmid":"28561591","id":"PMC_28561591","title":"Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28561591","citation_count":44,"is_preprint":false},{"pmid":"25221649","id":"PMC_25221649","title":"Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4.","date":"2014","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/25221649","citation_count":44,"is_preprint":false},{"pmid":"24107417","id":"PMC_24107417","title":"TAF-4 is required for the life extension of isp-1, clk-1 and tpk-1 Mit mutants.","date":"2013","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/24107417","citation_count":42,"is_preprint":false},{"pmid":"28581641","id":"PMC_28581641","title":"Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28581641","citation_count":40,"is_preprint":false},{"pmid":"8939941","id":"PMC_8939941","title":"Identification and characterization of the CLK1 gene product, a novel CaM kinase-like protein kinase from the yeast Saccharomyces cerevisiae.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8939941","citation_count":40,"is_preprint":false},{"pmid":"11729148","id":"PMC_11729148","title":"Phenotypic and suppressor analysis of defecation in clk-1 mutants reveals that reaction to changes in temperature is an active process in Caenorhabditis elegans.","date":"2001","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11729148","citation_count":39,"is_preprint":false},{"pmid":"29866747","id":"PMC_29866747","title":"Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1-S Checkpoint.","date":"2018","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29866747","citation_count":37,"is_preprint":false},{"pmid":"24869919","id":"PMC_24869919","title":"N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24869919","citation_count":36,"is_preprint":false},{"pmid":"23237976","id":"PMC_23237976","title":"Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.","date":"2012","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23237976","citation_count":36,"is_preprint":false},{"pmid":"29802995","id":"PMC_29802995","title":"Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29802995","citation_count":35,"is_preprint":false},{"pmid":"11387338","id":"PMC_11387338","title":"Mouse CLK-1 is imported into mitochondria by an unusual process that requires a leader sequence but no membrane potential.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11387338","citation_count":33,"is_preprint":false},{"pmid":"28692292","id":"PMC_28692292","title":"Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28692292","citation_count":32,"is_preprint":false},{"pmid":"22673832","id":"PMC_22673832","title":"Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts.","date":"2012","source":"Planta medica","url":"https://pubmed.ncbi.nlm.nih.gov/22673832","citation_count":31,"is_preprint":false},{"pmid":"20923139","id":"PMC_20923139","title":"The aging-associated enzyme CLK-1 is a member of the carboxylate-bridged diiron family of proteins.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20923139","citation_count":31,"is_preprint":false},{"pmid":"31176694","id":"PMC_31176694","title":"Regulation of influenza A virus mRNA splicing by CLK1.","date":"2019","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/31176694","citation_count":30,"is_preprint":false},{"pmid":"30731399","id":"PMC_30731399","title":"New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.","date":"2019","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30731399","citation_count":30,"is_preprint":false},{"pmid":"30108587","id":"PMC_30108587","title":"CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and Mucosa.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30108587","citation_count":29,"is_preprint":false},{"pmid":"18040075","id":"PMC_18040075","title":"Immunolocalization of a novel collectin CL-K1 in murine tissues.","date":"2007","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/18040075","citation_count":29,"is_preprint":false},{"pmid":"36262046","id":"PMC_36262046","title":"An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications.","date":"2022","source":"Medicinal research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/36262046","citation_count":28,"is_preprint":false},{"pmid":"25710878","id":"PMC_25710878","title":"Genetic variation of COLEC10 and COLEC11 and association with serum levels of collectin liver 1 (CL-L1) and collectin kidney 1 (CL-K1).","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25710878","citation_count":28,"is_preprint":false},{"pmid":"12893826","id":"PMC_12893826","title":"Sensitivity of Caenorhabditis elegans clk-1 mutants to ubiquinone side-chain length reveals multiple ubiquinone-dependent processes.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12893826","citation_count":28,"is_preprint":false},{"pmid":"26540031","id":"PMC_26540031","title":"Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment.","date":"2015","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26540031","citation_count":27,"is_preprint":false},{"pmid":"28404998","id":"PMC_28404998","title":"A single biochemical activity underlies the pleiotropy of the aging-related protein CLK-1.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28404998","citation_count":26,"is_preprint":false},{"pmid":"10373327","id":"PMC_10373327","title":"Orthologues of the Caenorhabditis elegans longevity gene clk-1 in mouse and human.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10373327","citation_count":25,"is_preprint":false},{"pmid":"14517217","id":"PMC_14517217","title":"Molecular mechanism of maternal rescue in the clk-1 mutants of Caenorhabditis elegans.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14517217","citation_count":24,"is_preprint":false},{"pmid":"16648490","id":"PMC_16648490","title":"Uncoupling the pleiotropic phenotypes of clk-1 with tRNA missense suppressors in Caenorhabditis elegans.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16648490","citation_count":24,"is_preprint":false},{"pmid":"33811140","id":"PMC_33811140","title":"CLK1 reorganizes the splicing factor U1-70K for early spliceosomal protein assembly.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33811140","citation_count":22,"is_preprint":false},{"pmid":"26443864","id":"PMC_26443864","title":"Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26443864","citation_count":18,"is_preprint":false},{"pmid":"30323815","id":"PMC_30323815","title":"Development of a Quantitative Assay for the Characterization of Human Collectin-11 (CL-11, CL-K1).","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30323815","citation_count":17,"is_preprint":false},{"pmid":"18343482","id":"PMC_18343482","title":"Clk-1 deficiency induces apoptosis associated with mitochondrial dysfunction in mouse embryos.","date":"2008","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/18343482","citation_count":17,"is_preprint":false},{"pmid":"27940419","id":"PMC_27940419","title":"Novel CLK1 inhibitors based on N-aryloxazol-2-amine skeleton - A possible way to dual VEGFR2 TK/CLK ligands.","date":"2016","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27940419","citation_count":16,"is_preprint":false},{"pmid":"26896709","id":"PMC_26896709","title":"Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2.","date":"2016","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26896709","citation_count":15,"is_preprint":false},{"pmid":"25807310","id":"PMC_25807310","title":"Lectin complement protein Collectin 11 (CL-K1) and susceptibility to urinary schistosomiasis.","date":"2015","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25807310","citation_count":14,"is_preprint":false},{"pmid":"11511092","id":"PMC_11511092","title":"Mouse coq7/clk-1 orthologue rescued slowed rhythmic behavior and extended life span of clk-1 longevity mutant in Caenorhabditis elegans.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11511092","citation_count":13,"is_preprint":false},{"pmid":"34811513","id":"PMC_34811513","title":"Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34811513","citation_count":12,"is_preprint":false},{"pmid":"36437406","id":"PMC_36437406","title":"CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/36437406","citation_count":12,"is_preprint":false},{"pmid":"11959146","id":"PMC_11959146","title":"CLK-1 protein has DNA binding activity specific to O(L) region of mitochondrial DNA.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11959146","citation_count":11,"is_preprint":false},{"pmid":"32866611","id":"PMC_32866611","title":"Expression, purification and crystallization of CLK1 kinase - A potential target for antiviral therapy.","date":"2020","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/32866611","citation_count":10,"is_preprint":false},{"pmid":"22733544","id":"PMC_22733544","title":"A MAP kinase gene, Clk1, is required for conidiation and pathogenicity in the phytopathogenic fungus Curvularia lunata.","date":"2012","source":"Journal of basic microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22733544","citation_count":10,"is_preprint":false},{"pmid":"22244837","id":"PMC_22244837","title":"Restoration of the behavioral rates and lifespan in clk-1 mutant nematodes in response to exogenous coenzyme Q(10).","date":"2012","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/22244837","citation_count":10,"is_preprint":false},{"pmid":"39251328","id":"PMC_39251328","title":"Regulatory interplay between SR proteins governs CLK1 kinase splice variants production.","date":"2024","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39251328","citation_count":8,"is_preprint":false},{"pmid":"34128702","id":"PMC_34128702","title":"A CLK1-KKT2 Signaling Pathway Regulating Kinetochore Assembly in Trypanosoma brucei.","date":"2021","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/34128702","citation_count":8,"is_preprint":false},{"pmid":"33668683","id":"PMC_33668683","title":"5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33668683","citation_count":8,"is_preprint":false},{"pmid":"35635953","id":"PMC_35635953","title":"Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker.","date":"2022","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35635953","citation_count":8,"is_preprint":false},{"pmid":"33581333","id":"PMC_33581333","title":"Elevated mitochondrial DNA copy number found in ubiquinone-deficient clk-1 mutants is not rescued by ubiquinone precursor 2-4-dihydroxybenzoate.","date":"2021","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/33581333","citation_count":8,"is_preprint":false},{"pmid":"25106098","id":"PMC_25106098","title":"Extended lifespan, reduced body size and leg skeletal muscle mass, and decreased mitochondrial function in clk-1 transgenic mice.","date":"2014","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/25106098","citation_count":8,"is_preprint":false},{"pmid":"39693605","id":"PMC_39693605","title":"CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis.","date":"2025","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39693605","citation_count":7,"is_preprint":false},{"pmid":"40253440","id":"PMC_40253440","title":"Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40253440","citation_count":7,"is_preprint":false},{"pmid":"12753928","id":"PMC_12753928","title":"Complementation of Escherichia coli ubiF mutation by Caenorhabditis elegans CLK-1, a product of the longevity gene of the nematode worm.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12753928","citation_count":7,"is_preprint":false},{"pmid":"40840404","id":"PMC_40840404","title":"Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy.","date":"2025","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/40840404","citation_count":6,"is_preprint":false},{"pmid":"36580731","id":"PMC_36580731","title":"Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity.","date":"2022","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36580731","citation_count":6,"is_preprint":false},{"pmid":"34526909","id":"PMC_34526909","title":"Inhibition of a Novel CLK1-THRAP3-PPARγ Axis Improves Insulin Sensitivity.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34526909","citation_count":6,"is_preprint":false},{"pmid":"38180157","id":"PMC_38180157","title":"CL-K1 Promotes Complement Activation and Regulates Opsonophagocytosis of Macrophages with CD93 Interaction in a Primitive Vertebrate.","date":"2024","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/38180157","citation_count":6,"is_preprint":false},{"pmid":"33662541","id":"PMC_33662541","title":"Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors.","date":"2021","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/33662541","citation_count":5,"is_preprint":false},{"pmid":"19194796","id":"PMC_19194796","title":"Molecular cloning, expression, and chromosomal mapping of the porcine CDC-2-like kinase 1 (CLK1) gene.","date":"2009","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19194796","citation_count":5,"is_preprint":false},{"pmid":"39149264","id":"PMC_39149264","title":"Characterization of aberrant splicing in pediatric central nervous system tumors reveals CLK1 as a candidate oncogenic dependency.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39149264","citation_count":5,"is_preprint":false},{"pmid":"38009092","id":"PMC_38009092","title":"SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4.","date":"2023","source":"Current research in chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38009092","citation_count":4,"is_preprint":false},{"pmid":"40404917","id":"PMC_40404917","title":"YTHDC1 orchestrates oncogenic splicing via the CLK1-SRSF1 splicing machinery to regulate castration-resistant prostate cancer progression.","date":"2025","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40404917","citation_count":2,"is_preprint":false},{"pmid":"35801494","id":"PMC_35801494","title":"Induction of beige-like adipocyte markers and functions in 3T3-L1 cells by Clk1 and PKCβII inhibitory molecules.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35801494","citation_count":2,"is_preprint":false},{"pmid":"34770981","id":"PMC_34770981","title":"Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34770981","citation_count":2,"is_preprint":false},{"pmid":"39430953","id":"PMC_39430953","title":"Design, synthesis, and structure-activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors.","date":"2024","source":"RSC medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39430953","citation_count":2,"is_preprint":false},{"pmid":"40994280","id":"PMC_40994280","title":"Discovery and Characterization of Cell-Permeable Inhibitors of Leishmania mexicana CLK1 Using an In-Cell Target Engagement Assay.","date":"2025","source":"ACS infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40994280","citation_count":1,"is_preprint":false},{"pmid":"36780830","id":"PMC_36780830","title":"Rational design and appraisal of selective Cdc2-Like kinase 1 (Clk1) inhibitors as novel autophagy inducers for the treatment of acute liver injury (ALI).","date":"2023","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36780830","citation_count":1,"is_preprint":false},{"pmid":"36615235","id":"PMC_36615235","title":"Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36615235","citation_count":1,"is_preprint":false},{"pmid":"28000414","id":"PMC_28000414","title":"Identification of CLK1 Inhibitors by a Fragment-linking Based Virtual Screening.","date":"2016","source":"Molecular informatics","url":"https://pubmed.ncbi.nlm.nih.gov/28000414","citation_count":1,"is_preprint":false},{"pmid":"41686262","id":"PMC_41686262","title":"CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer.","date":"2026","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/41686262","citation_count":0,"is_preprint":false},{"pmid":"41191919","id":"PMC_41191919","title":"Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching.","date":"2026","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/41191919","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48917,"output_tokens":7914,"usd":0.132731,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17563,"output_tokens":6062,"usd":0.119682,"stage2_stop_reason":"end_turn"},"total_usd":0.252413,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"CLK1 kinase phosphorylates SR proteins and regulates alternative pre-mRNA splicing in vivo; the peptide domain encoded by the alternatively spliced exon of CLK1 is essential for this regulatory activity. CLK1 also autoregulates its own pre-mRNA splicing, producing catalytically active (CLK1) and truncated inactive (CLK1T) isoforms.\",\n      \"method\": \"In vivo expression/transfection assays, alternative splicing analysis of CLK1 and adenovirus pre-mRNAs\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo demonstration with domain-deletion mutants, replicated across multiple pre-mRNA targets including autoregulation\",\n      \"pmids\": [\"9315658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"C. elegans CLK-1 protein is structurally and functionally conserved with yeast Cat5p/Coq7p, a metabolic regulator; clk-1 complements cat5/coq7 null mutants, demonstrating shared biochemical function at the level of cellular physiology.\",\n      \"method\": \"Genetic complementation of yeast coq7/cat5 null mutants with C. elegans clk-1\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct genetic complementation across species, replicated in multiple subsequent studies\",\n      \"pmids\": [\"9020081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Yeast Coq7p/Cat5p (CLK-1 homologue) is a mitochondrial inner membrane protein directly involved in ubiquinone biosynthesis; the defect in gluconeogenic gene activation in coq7/cat5 null mutants is a general consequence of defective respiration, not a direct regulatory role.\",\n      \"method\": \"Subcellular fractionation, mitochondrial localization assays, respiratory growth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct fractionation and functional assays, consistent with multiple independent studies\",\n      \"pmids\": [\"9452453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"C. elegans CLK-1 fused to GFP is fully active and localizes to the mitochondria of all somatic cells. Overexpression of CLK-1 in wild-type worms increases mitochondrial activity, accelerates behavioral rates during aging, and shortens lifespan, demonstrating that clk-1 regulates and controls these processes.\",\n      \"method\": \"GFP fusion live imaging, in vivo dye-uptake assay for mitochondrial membrane potential, succinate cytochrome c reductase activity assay, overexpression studies\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization by GFP fusion, multiple functional assays, overexpression phenotype in vivo\",\n      \"pmids\": [\"10202142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human CLK-1 functionally complements yeast coq7 deletion mutants for growth on non-fermentable carbon sources, demonstrating conservation of the ubiquinone biosynthesis function from nematode to human.\",\n      \"method\": \"Yeast complementation assay with human CLK-1 cDNA introduced into coq7 deletion strains\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct complementation assay, single lab but definitive functional test\",\n      \"pmids\": [\"10501970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CLK1 and CLK2 phosphorylate PTP-1B in vitro and in vivo, activating its phosphatase activity approximately 2-5-fold. Phosphorylation of PTP-1B at Ser50 by CLK1 is responsible for enzymatic activation.\",\n      \"method\": \"In vitro kinase assay, co-expression in HEK293 cells, site-directed mutagenesis (Ser50)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution plus mutagenesis plus cellular validation, single lab\",\n      \"pmids\": [\"10480872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The N-terminus of CLK1 acts as a negative regulatory domain; N-terminal truncation causes a 45-fold increase in Vmax. CLK1 activity is positively regulated by phosphorylation on tyrosine residues or serine/threonine residues, and negatively regulated by phosphorylation of a subset of serine/threonine residues within the catalytic domain (PP2A treatment increases activity 2-6-fold; combined tyrosine + serine/threonine dephosphorylation abolishes activity). CLK1 protein is primarily found in the cytoplasm of neuronal cells, with only a small fraction in the nucleus.\",\n      \"method\": \"N-terminal truncation mutants, in vitro kinase assays, phosphatase (PP2A, tyrosine phosphatase) treatment, subcellular fractionation, immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biochemical methods including truncation, phosphatase treatment, and localization, single lab\",\n      \"pmids\": [\"10954422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CLK-1 is absolutely required for ubiquinone (UQ9) biosynthesis in C. elegans; clk-1 mutant mitochondria lack UQ9 and instead accumulate demethoxyubiquinone (DMQ9). DMQ9 can function as an electron carrier for both complex I and complex II, explaining near-normal respiration in mutants.\",\n      \"method\": \"Lipid analysis by HPLC/MS, synthesis of DMQ2, in vitro respiratory chain activity assays with isolated mitochondria\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical identification of substrate accumulation plus functional reconstitution, replicated independently\",\n      \"pmids\": [\"11244089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Coq7/CLK-1 is a member of the di-iron carboxylate protein family based on a conserved sequence motif for iron ligands; the Pseudomonas aeruginosa Coq7 ortholog complements an E. coli ubiF mutant lacking 5-demethoxyubiquinone hydroxylase activity, providing evidence that Coq7 directly functions as a hydroxylase.\",\n      \"method\": \"Sequence analysis, identification of di-iron motif, bacterial complementation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bacterial complementation confirms hydroxylase function, di-iron motif identification by sequence; single lab\",\n      \"pmids\": [\"11435415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse CLK-1 (mCLK1) is imported into the mitochondrial matrix where a leader sequence is cleaved and the protein becomes loosely associated with the inner membrane. Unusually, this import does not require a mitochondrial membrane potential, unlike all other known mitochondrial proteins with cleavable pre-sequences.\",\n      \"method\": \"Subcellular fractionation, mitochondrial import assays with membrane potential disruption, pulse-chase/processing assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation and functional import assays with membrane potential manipulation, mechanistically definitive\",\n      \"pmids\": [\"11387338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human PRP4 (hPRP4) interacts directly with CLK1 at its C-terminus; the RS-rich domain of hPRP4 is phosphorylated by CLK1 in vitro. Overexpression of active CLK1 causes redistribution of hPRP4 from nuclear speckles to a diffuse nucleoplasmic pattern, while catalytically inactive CLK1 does not.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, indirect immunofluorescence, overexpression of wild-type and kinase-dead CLK1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction, in vitro phosphorylation, and functional localization change all demonstrated, single lab\",\n      \"pmids\": [\"11418604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"C. elegans CLK-1 and mouse CLK-1 have DNA-binding activity specific to the OL region of mitochondrial DNA; this DNA-binding activity is inhibited by ADP and is altered by clk-1 mutations that extend lifespan, suggesting a possible role in mtDNA replication or transcription regulation.\",\n      \"method\": \"In vitro DNA-binding assay (electrophoretic mobility shift), ADP inhibition experiment\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single in vitro binding assay, single lab, no functional validation of the DNA-binding activity in vivo\",\n      \"pmids\": [\"11959146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CLK-1 is a hydroxylase catalyzing the conversion of demethoxyubiquinone to hydroxyubiquinone (a ubiquinone precursor); C. elegans CLK-1 expressed from a plasmid rescues aerobic respiration on a non-fermentable carbon source and restores ubiquinone biosynthesis in an E. coli ubiF mutant, providing direct evidence of demethoxyubiquinone hydroxylase activity.\",\n      \"method\": \"Bacterial complementation of E. coli ubiF mutant, respiratory growth assay, ubiquinone biosynthesis assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic complementation demonstrating hydroxylase activity, consistent with multiple independent lines of evidence\",\n      \"pmids\": [\"12753928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mouse CLK-1 (MCLK1) belongs to the carboxylate-bridged diiron protein family, confirmed by Mössbauer and EPR spectroscopy. NADH can serve directly as a reductant for catalytic activation of dioxygen and substrate oxidation by MCLK1 in vitro, with no requirement for an additional reductase protein component.\",\n      \"method\": \"Mössbauer spectroscopy, EPR spectroscopy, in vitro enzymatic activity assay with NADH and quinone substrates\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — spectroscopic structural characterization plus in vitro enzymatic activity with defined reductant, single lab but rigorous biophysical methods\",\n      \"pmids\": [\"20923139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Splicing of CLK1/4 mRNAs is normally suspended with intron-retaining intermediate forms pooled in the nucleus. Under stress conditions (heat shock, osmotic stress), maturation of CLK1/4 mRNAs is promoted, leading to translation of CLK1/4 proteins that catalyze rephosphorylation of SR proteins (especially SRSF4 and SRSF10), thereby restoring the phosphorylation state of SR proteins after stress-induced dephosphorylation.\",\n      \"method\": \"RT-PCR for intron-retaining forms, CLK-specific inhibitor TG003, stress induction, SR protein phosphorylation assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition plus stress induction with defined molecular readouts, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"21949414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CLK1 phosphorylates SPF45 (alternative splicing factor 45) on eight serine residues. CLK1 phosphorylation of SPF45 regulates its splice-site utilization (Fas mRNA exon 6 exclusion), enhances SPF45 protein stability (CLK1 inhibition increases SPF45 proteasomal degradation), and promotes ovarian cancer cell migration and invasion.\",\n      \"method\": \"In vitro kinase assay, mutagenesis of phosphorylation sites, CLK1 inhibition/overexpression, proteasome inhibitor experiments, RT-PCR for Fas splicing, migration/invasion assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay with mutagenesis plus cellular functional validation across multiple readouts, single lab\",\n      \"pmids\": [\"23519612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-terminus of CLK1 contacts both the CLK1 kinase domain and the RS domain of SR protein SRSF1, facilitating hyperphosphorylation and cooperative RNA binding by SRSF1. The N-terminus enhances total phosphoryl content of SRSF1, SRSF2, SRSF5 and Tra2β1 by 2-3-fold, acting as a bridge connecting the kinase domain to the RS domain substrate.\",\n      \"method\": \"In vitro kinase assays with truncation mutants, RNA binding assays (EMSA), phosphorylation stoichiometry measurements\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro with N-terminal domain mutants and multiple substrates, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24869919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"C. elegans CLK-1 has a distinct nuclear form that independently regulates lifespan through a retrograde signaling pathway conserved from C. elegans to humans. Nuclear CLK-1 responds to mitochondrial reactive oxygen species, modulates gene expression to regulate mitochondrial ROS metabolism and the mitochondrial unfolded protein response.\",\n      \"method\": \"Subcellular fractionation, nuclear/mitochondrial CLK-1 separation, ROS measurement, lifespan assays with nuclear-specific CLK-1 constructs, gene expression analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation plus functional lifespan and gene expression data, but contradicted by a subsequent paper (PMID 28404998) that failed to detect nuclear enrichment\",\n      \"pmids\": [\"25961505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CLK1 uses N-terminus-induced oligomerization (rather than a classical docking groove or adaptor) as a substrate selection mechanism for SR proteins. The disordered N-terminus induces oligomerization necessary for preferential phosphorylation of SRSF1 over non-physiological substrates; CLK1 self-association occurs in the nucleus and drives localization to nuclear speckles.\",\n      \"method\": \"In vitro kinase specificity assays at varying concentrations, size-exclusion chromatography, N-terminal truncation mutants, nuclear localization by immunofluorescence\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical approaches supporting oligomerization mechanism, single lab\",\n      \"pmids\": [\"26443864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SRPK1 interacts with an RS-like domain in the N-terminus of CLK1 to facilitate release of phosphorylated SR proteins from CLK1, enabling efficient splice-site recognition and spliceosome assembly. CLK1 alone cannot release phosphorylated SR proteins (thus inactivating them); SRPK1 provides the release function in a symbiotic kinase system.\",\n      \"method\": \"Co-immunoprecipitation, in vitro splicing assays, CLK1/SRPK1 interaction mapping, SR protein release assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, functional in vitro splicing assay, domain mapping; single lab with multiple orthogonal methods and mechanistically rigorous\",\n      \"pmids\": [\"27397683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"All phenotypes of C. elegans clk-1 mutants (behavioral, developmental, lifespan, mitochondrial quality control gene expression) result exclusively from loss of ubiquinone biosynthesis; pharmacological restoration of UQ biosynthesis rescues all phenotypes. Nuclear localization of MCLK1/CLK-1 could not be detected by immunohistochemistry or protein purification.\",\n      \"method\": \"Pharmacological UQ restoration in clk-1 null mutants, immunohistochemical localization in worms, subcellular fractionation of mammalian cells, lifespan and behavioral assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological rescue plus negative localization result with multiple methods, directly addresses disputed nuclear function claim\",\n      \"pmids\": [\"28404998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CLK1 inhibition (TG693, an orally available inhibitor) promotes skipping of the mutated exon 31 in DMD patient-derived cells and increases production of functional exon-31-skipped dystrophin. Oral administration to mice inhibits phosphorylation of SR protein substrates of CLK1 and modulates pre-mRNA splicing in skeletal muscle in vivo.\",\n      \"method\": \"Patient-derived cell splicing assays, Western blotting for dystrophin, oral dosing in mice, SR protein phosphorylation assays in skeletal muscle\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cellular and in vivo functional validation of CLK1 substrate phosphorylation and splicing modulation, single lab\",\n      \"pmids\": [\"28555643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CLK1 regulates splicing of influenza A virus mRNA segment 7 (encoding M1/M2 proteins); CLK1 knockdown reduces influenza replication and increases splicing of segment 7. CLK1-/- mice support lower levels of influenza virus replication than wild-type mice.\",\n      \"method\": \"siRNA knockdown in A549 cells, CLK1 knockout mice challenged with influenza, RT-PCR for M1/M2 splicing, viral titer assays\",\n      \"journal\": \"Antiviral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both cell-based knockdown and in vivo knockout with defined molecular readout (viral mRNA splicing), single lab\",\n      \"pmids\": [\"31176694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Trypanosoma brucei CLK1 (KKT10) is a kinetochore kinase; amidobenzimidazole (AB1) inhibitors irreversibly inhibit TbCLK1 via a Michael acceptor bond with Cys215 in the ATP-binding pocket. Chemical inhibition of CLK1 impairs inner kinetochore recruitment and compromises cell-cycle progression leading to cell death.\",\n      \"method\": \"Co-crystal structure of TbCLK1 with AB1 inhibitor, biochemical target deconvolution with 29 kinase overexpression mutants, cell biology/cell-cycle assays\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus biochemical inhibition mechanism plus genetic target validation and cell-cycle phenotype\",\n      \"pmids\": [\"32661312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLK1 phosphorylates Ser-226 in the C-terminus of U1-70K, releasing it from subnuclear granules and facilitating interaction with U1 snRNP and SR protein SRSF1. CLK1 breaks contacts between the C-terminus and the RNA recognition motif (RRM) of U1-70K, permitting stable interactions with U1 snRNP-associated proteins. Nuclear induction of SRPK1 facilitates CLK1 dissociation from U1-70K to recycle the kinase.\",\n      \"method\": \"Quantitative phosphoproteomics, in vitro kinase assays, co-immunoprecipitation, subnuclear localization by immunofluorescence, SRPK1 nuclear induction experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphoproteomics identification plus in vitro validation plus functional protein-protein interaction assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33811140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLK1 phosphorylates SRSF5 at Ser250, which inhibits METTL14 exon 10 skipping while promoting Cyclin L2 exon 6.3 skipping in pancreatic cancer cells. The CLK1/SRSF5 axis thereby promotes pancreatic cancer cell growth and metastasis through these two alternative splicing events.\",\n      \"method\": \"Phosphorylation mass spectrometry identifying SRSF5-Ser250, RNA-seq for splicing events, RIP assays, RNA pulldown, CLIP-qPCR, in vitro and in vivo tumor models\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation site identified by MS with functional splicing validation by multiple RNA methods, single lab\",\n      \"pmids\": [\"33849617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Trypanosoma brucei KKT2 is a direct substrate of CLK1; phosphorylation of KKT2 at Ser508 by CLK1 is essential for KKT2 function and for kinetochore assembly. Chemical inhibition of CLK1 with AB1 impairs inner kinetochore recruitment. CLK1 and aurora kinase AUK1 are in separate regulatory pathways for KKT2 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis of KKT2-S508, chemical inhibition with AB1, immunofluorescence for kinetochore assembly, AUK1 inhibitor epistasis experiment\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation plus mutagenesis plus functional kinetochore assembly assay, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"34128702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLK1 inhibition of CLK1 downregulates the functional ERCC1-202 isoform through altered alternative splicing, resulting in enhanced DNA damage and apoptosis. CLK1 knockdown is synthetically lethal with PARP inhibitors in ovarian cancer, and the combination of olaparib with CLK1 inhibitor TG003 shows potent anti-proliferative effects in vitro and in vivo.\",\n      \"method\": \"Genome-wide CRISPR-Cas9 screen, siRNA knockdown, CLK1 inhibitor TG003, ERCC1 isoform RT-PCR, DNA damage markers, in vivo xenograft experiments\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR screen plus mechanistic validation of ERCC1 isoform switching, single lab\",\n      \"pmids\": [\"41191919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLK1 phosphorylates THRAP3 at Ser243; phosphorylated THRAP3 interacts with phosphorylated PPARγ to impair adipose tissue browning and insulin sensitivity. CLK1 genetic knockout or chemical inhibition in mice ameliorates diet-induced obesity and insulin resistance.\",\n      \"method\": \"Phosphoproteomics, co-immunoprecipitation, site-directed mutagenesis (Ser243), CLK1 knockout mice, metabolic phenotyping\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics plus co-IP plus in vivo genetic validation, single lab\",\n      \"pmids\": [\"34526909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CLK1 exon 4 inclusion is controlled by a balance between TRA2 protein activators and CLK1-phosphorylated SRSF3 as a repressor; SRSF10 and SRSF12 interact with TRA2 proteins to prevent their enhancer activity, allowing SRSF3 to enforce exon 4 skipping. An exonic enhancer in exon 4 interacts with TRA2β. CLK1 kinase inhibitors antagonize the repressor activity of SRSF10, SRSF12, and SRSF3 in this autoregulatory loop.\",\n      \"method\": \"CRISPR/Cas9 knockouts, tagged protein expression, CRISPR/dCas13Rx, RNA immunoprecipitation, CLK1 inhibitor treatment\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic tools and RNA-protein interaction assays, single lab\",\n      \"pmids\": [\"39251328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLK1 activates YAP to promote intrahepatic cholangiocarcinoma (ICC); WWC2 was identified as a potential mediator of the CLK1-YAP cascade by 4D label-free mass spectrometry and co-immunoprecipitation. Loss of YAP completely retards AKT/CLK1-induced ICC tumor formation in mice.\",\n      \"method\": \"RNA sequencing, 4D label-free mass spectrometry, co-immunoprecipitation, hydrodynamic transfection mouse model, YAP inhibition/deletion experiments\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS identification of binding partner plus co-IP plus in vivo genetic rescue, single lab\",\n      \"pmids\": [\"39693605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"cALG8 (a circRNA) functions as a protein scaffold enabling CLK1 to phosphorylate SRSF7 at Ser231, facilitating SRSF7-dependent alternative splicing of ATM kinase to produce the ATM203 variant, which enhances ATM translation, DNA damage repair, and immune microenvironment remodeling to promote gemcitabine resistance in pancreatic cancer.\",\n      \"method\": \"LC-MS for RNA-binding proteins, molecular biology validation of cALG8-CLK1-SRSF7 interaction, phospho-specific detection, splice variant analysis, PDO/PDX models\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry identification plus mechanistic validation in patient-derived models, single lab\",\n      \"pmids\": [\"40840404\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CLK1 (COQ7/CLK-1) is a dual-specificity kinase with two well-established mechanistic roles: (1) as a mitochondrial diiron hydroxylase that catalyzes the conversion of demethoxyubiquinone to hydroxyubiquinone in the ubiquinone biosynthesis pathway (a function conserved from bacteria to humans), imported into the mitochondrial matrix via an unusual membrane-potential-independent mechanism; and (2) as a nuclear serine-arginine protein kinase that hyperphosphorylates SR splicing factors (including SRSF1, SRSF2, SRSF4, SRSF5, SRSF10) and other spliceosomal components (U1-70K, SPF45), with substrate selectivity conferred by N-terminus-driven oligomerization, and whose activity is regulated through a symbiotic relationship with SRPK1 that enables release of phosphorylated SR proteins to promote spliceosome assembly; CLK1 also autoregulates its own alternative splicing and controls diverse downstream splicing events linked to cancer, viral replication, and neurodegenerative disease.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"The CLK1 symbol in this corpus resolves to two biochemically distinct proteins that share the historical \\\"clk-1\\\" designation: a nuclear/cytoplasmic dual-specificity SR-protein kinase, and the mitochondrial ubiquinone-biosynthesis enzyme encoded by the COQ7/CLK-1 ortholog. The kinase activity governs alternative pre-mRNA splicing by hyperphosphorylating SR splicing factors, and CLK1 autoregulates its own splicing to produce a catalytically active isoform and a truncated inactive isoform (CLK1T) through an exon-inclusion loop balanced between TRA2 activators and CLK1-phosphorylated SRSF3 repressor activity [#0, #29]. Substrate selectivity is conferred by the disordered N-terminus, which acts both as a negative regulatory domain and as a bridge that contacts the kinase domain and the RS domain of substrates such as SRSF1, driving N-terminus-induced oligomerization and localization to nuclear speckles [#6, #16, #18]. CLK1 phosphorylates a broad set of spliceosomal substrates — including SRSF5, U1-70K (Ser226), SPF45, and the splicing kinase target hPRP4 — to control splice-site usage and spliceosome assembly, and operates in a symbiotic system with SRPK1, which binds an RS-like motif in the CLK1 N-terminus to release phosphorylated SR proteins and recycle the kinase [#10, #15, #19, #24, #25]. Under cellular stress, suspended intron-retaining CLK1/4 transcripts mature to restore SR-protein phosphorylation [#14]. Through these splicing functions CLK1 modulates influenza M1/M2 segment-7 splicing and viral replication, DMD exon skipping, and multiple cancer-associated splicing programs (ERCC1, METTL14/Cyclin L2, ATM), the latter conferring PARP-inhibitor synthetic lethality and chemoresistance phenotypes [#21, #22, #25, #27, #31]. The independently characterized mitochondrial COQ7/CLK-1 protein is a carboxylate-bridged diiron hydroxylase that converts demethoxyubiquinone to hydroxyubiquinone in ubiquinone biosynthesis, a function conserved from bacteria and yeast to nematode and human, imported into the matrix by an unusual membrane-potential-independent mechanism; loss of this activity, not any nuclear role, accounts for the C. elegans clk-1 lifespan and mitochondrial phenotypes [#1, #4, #7, #9, #12, #13, #20]. In the divergent trypanosome ortholog (KKT10), CLK1 instead functions as a kinetochore kinase that phosphorylates KKT2 to drive kinetochore assembly and cell-cycle progression [#23, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that CLK1 is a functional regulator of alternative splicing and uncovered its self-governing isoform switch, defining the kinase as both an effector and target of splicing control.\",\n      \"evidence\": \"In vivo transfection and alternative splicing analysis with domain-deletion mutants on CLK1 and adenovirus pre-mRNAs\",\n      \"pmids\": [\"9315658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the full SR substrate spectrum\", \"Mechanism of substrate selection not yet defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved that the clk-1 gene shared with the splicing kinase symbol actually encodes a conserved mitochondrial metabolic enzyme, separating the metabolic ortholog from the kinase function.\",\n      \"evidence\": \"Cross-species genetic complementation of yeast coq7/cat5 nulls with C. elegans and human clk-1, plus GFP localization in worms\",\n      \"pmids\": [\"9020081\", \"9452453\", \"10501970\", \"10202142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet define the enzymatic reaction catalyzed\", \"Did not address whether the kinase and metabolic activities reside in the same human protein\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed CLK1 kinase has substrates beyond SR proteins, demonstrating phosphorylation-dependent activation of PTP-1B at Ser50.\",\n      \"evidence\": \"In vitro kinase assay, HEK293 co-expression, and Ser50 site-directed mutagenesis\",\n      \"pmids\": [\"10480872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of PTP-1B activation not established\", \"Not linked to splicing pathway\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the N-terminus as an autoinhibitory domain and revealed multi-site phosphorylation as a bidirectional regulator of kinase output, framing CLK1 activity as tightly tuned.\",\n      \"evidence\": \"N-terminal truncation mutants, in vitro kinase assays, PP2A/tyrosine phosphatase treatment, and subcellular fractionation\",\n      \"pmids\": [\"10954422\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identities of the regulatory phospho-sites not mapped\", \"Upstream kinases/phosphatases not identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Pinned the metabolic ortholog's role to ubiquinone biosynthesis and clarified why respiration persists in mutants, by identifying DMQ9 accumulation as a partially functional electron carrier.\",\n      \"evidence\": \"HPLC/MS lipid analysis and in vitro respiratory chain assays in C. elegans mitochondria, plus mitochondrial import assays with membrane-potential disruption\",\n      \"pmids\": [\"11244089\", \"11387338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of potential-independent import not structurally defined\", \"Catalytic chemistry not yet characterized\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified hPRP4 as a direct CLK1 interactor and substrate, extending kinase targets to core spliceosomal regulators and linking CLK1 activity to speckle dynamics.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assay, and immunofluorescence with wild-type vs kinase-dead CLK1\",\n      \"pmids\": [\"11418604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional splicing consequence of hPRP4 phosphorylation not quantified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the metabolic ortholog as a diiron-carboxylate demethoxyubiquinone hydroxylase, assigning its precise enzymatic reaction.\",\n      \"evidence\": \"E. coli ubiF complementation, di-iron motif analysis, and Mössbauer/EPR spectroscopy with NADH-driven in vitro turnover\",\n      \"pmids\": [\"11435415\", \"12753928\", \"20923139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human enzyme structure not solved\", \"Physiological reductant in mammalian mitochondria not confirmed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected CLK1 isoform maturation to stress signaling, showing intron-retained transcripts are released to rephosphorylate SR proteins and restore splicing homeostasis.\",\n      \"evidence\": \"RT-PCR of intron-retaining forms, stress induction, and CLK inhibitor TG003 with SR phosphorylation readouts\",\n      \"pmids\": [\"21949414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal coupling stress to intron removal not defined\", \"SR substrate breadth under stress not fully mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Explained how CLK1 achieves SR-protein hyperphosphorylation, showing the N-terminus bridges the kinase and RS domains to enhance phosphoryl content and cooperative RNA binding.\",\n      \"evidence\": \"In vitro kinase assays with truncation mutants, EMSA, and phosphorylation stoichiometry on SRSF1/2/5 and Tra2β1\",\n      \"pmids\": [\"24869919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the N-terminal bridge not solved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Proposed N-terminus-induced oligomerization as the substrate-discrimination mechanism, distinguishing physiological from non-physiological targets without a docking groove.\",\n      \"evidence\": \"Concentration-dependent in vitro specificity assays, size-exclusion chromatography, and speckle localization\",\n      \"pmids\": [\"26443864\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Oligomer stoichiometry in cells not defined\", \"Single-lab biochemical model\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Advanced a contested model that a nuclear CLK-1 form drives lifespan via mitochondrial ROS retrograde signaling, independent of the metabolic enzyme role.\",\n      \"evidence\": \"Subcellular fractionation, nuclear-specific constructs, ROS measurement, and lifespan assays in C. elegans\",\n      \"pmids\": [\"25961505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear localization later not reproduced (#20)\", \"Mechanism of retrograde gene-expression control undefined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolved how phosphorylated SR proteins are released from the kinase, establishing a symbiotic CLK1–SRPK1 system required for spliceosome assembly.\",\n      \"evidence\": \"Reciprocal co-IP, domain mapping of the CLK1 N-terminal RS-like motif, and in vitro splicing/SR-release assays\",\n      \"pmids\": [\"27397683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo stoichiometry of CLK1:SRPK1 not measured\", \"Regulation of the handoff not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Definitively attributed all C. elegans clk-1 phenotypes to lost ubiquinone biosynthesis and failed to detect nuclear CLK-1, directly disputing the retrograde nuclear-signaling model.\",\n      \"evidence\": \"Pharmacological UQ restoration, immunohistochemistry, and fractionation in worms and mammalian cells\",\n      \"pmids\": [\"28404998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not exclude condition-specific nuclear pools\", \"Addresses the metabolic ortholog, not the human splicing kinase\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated translatable splicing control by CLK1, showing inhibition promotes therapeutic DMD exon skipping in patient cells and modulates SR phosphorylation in vivo.\",\n      \"evidence\": \"Patient-derived cell splicing assays, dystrophin Western blots, and oral TG693 dosing in mice\",\n      \"pmids\": [\"28555643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct SR substrate driving exon 31 skipping not specified\", \"Single-lab in vivo evidence\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped specific CLK1 phospho-sites and their splicing/assembly consequences across multiple substrates, building a residue-level picture of how CLK1 controls spliceosome dynamics and cancer-relevant splicing.\",\n      \"evidence\": \"Phosphoproteomics, in vitro kinase assays, mutagenesis, co-IP, and RNA-based splicing readouts on SPF45, U1-70K(Ser226), and SRSF5(Ser250)\",\n      \"pmids\": [\"23519612\", \"33811140\", \"33849617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Comprehensive substrate-site map still incomplete\", \"Cross-talk between sites not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a divergent role of the trypanosome CLK1 ortholog (KKT10) as a kinetochore kinase phosphorylating KKT2 to drive kinetochore assembly and cell-cycle progression.\",\n      \"evidence\": \"Co-crystal structure with AB1 inhibitor, target deconvolution with kinase mutants, in vitro kinase assay/mutagenesis of KKT2-Ser508, and cell-cycle assays\",\n      \"pmids\": [\"32661312\", \"34128702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship to the mammalian splicing-kinase function not established\", \"Whether human CLK1 has any kinetochore role unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked CLK1 splicing control to therapeutic vulnerabilities and metabolic disease, including PARP-inhibitor synthetic lethality via ERCC1 isoform switching and THRAP3-PPARγ-mediated insulin resistance.\",\n      \"evidence\": \"Genome-wide CRISPR screen, ERCC1 isoform RT-PCR, xenografts, and phosphoproteomics/co-IP plus CLK1 knockout metabolic phenotyping in mice\",\n      \"pmids\": [\"41191919\", \"34526909\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrate driving ERCC1-202 switching not pinpointed\", \"Single-lab in vivo metabolic models\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Dissected the molecular logic of CLK1 autoregulation, defining a TRA2-activator versus CLK1-phosphorylated SRSF3-repressor balance at exon 4.\",\n      \"evidence\": \"CRISPR/Cas9 knockouts, dCas13Rx, RNA immunoprecipitation, and CLK1 inhibitor treatment\",\n      \"pmids\": [\"39251328\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative contribution of each factor not resolved\", \"Single-lab system\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended CLK1's oncogenic splicing reach to chemoresistance and signaling, showing circRNA-scaffolded SRSF7 phosphorylation drives ATM splicing and a CLK1-YAP cascade in liver/pancreatic cancers.\",\n      \"evidence\": \"LC-MS for RNA-binding proteins, co-IP, phospho-specific and splice-variant analysis, and PDO/PDX and hydrodynamic mouse models\",\n      \"pmids\": [\"40840404\", \"39693605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CLK1-YAP mechanism (WWC2 role) not fully validated\", \"Single-lab models\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether the human CLK1 splicing kinase and the mitochondrial COQ7/CLK-1 hydroxylase are truly the same gene product or distinct proteins conflated by symbol history, and how their respective regulatory inputs integrate, remains unresolved in this corpus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No single study demonstrates both activities in one human protein\", \"Structural model of human kinase N-terminal regulation lacking\", \"In vivo SRPK1 handoff dynamics not quantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 10, 15, 16, 24, 25, 26]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [7, 8, 12, 13]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 14, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 3, 7, 9]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 14, 18, 24]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [10, 18]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 14, 19, 24, 29]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 12]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [23, 26]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [22, 25, 27, 30, 31]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SRPK1\", \"SRSF1\", \"U1-70K\", \"SPF45\", \"PRP4\", \"SRSF5\", \"KKT2\", \"PTP-1B\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}